Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photocurrent-driven transient symmetry breaking in the Weyl semimetal TaAs.

Nature materials·2021
Same author

Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44  TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13  TeV pp Collisions Recorded with the ATLAS Detector.

Physical review letters·2021
Same author

Medium-Induced Modification of Z-Tagged Charged Particle Yields in Pb+Pb Collisions at 5.02 TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Release and Transport of Flavors In Vivo: Physicochemical, Physiological, and Perceptual Considerations.

Comprehensive reviews in food science and food safety·2021
Same author

Observation and Measurement of Forward Proton Scattering in Association with Lepton Pairs Produced via the Photon Fusion Mechanism at ATLAS.

Physical review letters·2021

Related Experiment Videos

Cardiac sarcoidosis.

J Habersberger1, V Manins, A J Taylor

  • 1Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia. jhabers@optusnet.com.au

Internal Medicine Journal
|April 3, 2008
PubMed
Summary

Diagnosing cardiac sarcoidosis is challenging, but cardiac MRI shows promise for detecting the disease and monitoring treatment. Current treatments like corticosteroids lack proven survival benefits, and management of arrhythmias and heart failure remains complex.

Area of Science:

  • Cardiology
  • Immunology
  • Radiology

Background:

  • Cardiac sarcoidosis presents with diverse cardiac manifestations, including conduction abnormalities, heart failure, and arrhythmias.
  • The incidence of cardiac involvement in sarcoidosis varies geographically, significantly contributing to mortality.
  • Accurate diagnosis of cardiac sarcoidosis is hindered by the lack of a single, highly sensitive and specific diagnostic test.

Purpose of the Study:

  • To review the diagnostic challenges and therapeutic strategies for cardiac sarcoidosis.
  • To highlight the potential of advanced imaging techniques in diagnosing and managing the condition.
  • To discuss current treatment limitations and future directions in cardiac sarcoidosis management.

Main Methods:

  • Literature review of diagnostic modalities for cardiac sarcoidosis.

Related Experiment Videos

  • Analysis of current treatment protocols, including corticosteroids and heart failure management.
  • Evaluation of the role of cardiac magnetic resonance imaging (CMR) in disease detection and monitoring.
  • Discussion of management strategies for arrhythmias and the role of cardiac transplantation.

    • Main Results:

    • Gadolinium-enhanced MRI demonstrates high sensitivity and specificity for detecting cardiac sarcoidosis and its activity.
    • Corticosteroids are the primary treatment but lack demonstrated survival benefits in prospective trials.
    • Standard heart failure guidelines apply, but anti-arrhythmic treatment and the use of implantable cardioverter-defibrillators (ICDs) require further definition.
    • Cardiac transplantation is an option for select younger patients.

    Conclusions:

    • Cardiac MRI offers a promising tool for diagnosing and monitoring cardiac sarcoidosis.
    • Effective treatment strategies, particularly regarding long-term survival benefits and arrhythmia management, require further investigation.
    • Cardiac sarcoidosis generally carries a poor prognosis, emphasizing the need for improved diagnostic and therapeutic approaches.